ClinicalTrials.gov
public full text
Public Domain
Tranexamic Acid in Pediatric Cardiac Surgery
Tranexamic acid(TXA) is an antifibrinolytic agent to reduce blood loss in cardiac surgery. Previous seven RCTs comparing effects of TXA in pediatric cardiac surgery showed conflict results. The reason why they showed mixed results would be the imbalance of patients population with regard to presence of cyanosis. TXA would reduce blood loss in pediatric cardiac surgery with well balanced patients population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage#1009352
- TRANexamic Acid to Reduce Bleeding in BURN Surgery#1007095
- Tranexamic Acid in Abdominoplasty.#1032848
- Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage#1057683
- The Impact of Tranexamic Acid in Liver Resections: A Systematic Review#647463
Record · ID 827852
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive